Patent assignee · US · COMPANY

OTONOMY, INC.

🏢 View company profile →
42Patents
42Active
42Granted
54Portfolio score

Filing activity: Apr 21, 2009 → Mar 19, 2020 · 11 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8030297B2 Controlled release corticosteroid compositions and methods for the treatment of OTIC disorders Human Necessities 55 Active
US8399018B2 Controlled release ion channel modulator compositions and methods for the treatment of otic disorders Human Necessities 36 Active
US8318817B2 Controlled release antimicrobial compositions and methods for the treatment of otic disorders Human Necessities 33 Active
US8846770B2 Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders Human Necessities 32 Active
US8784870B2 Controlled release compositions for modulating free-radical induced damage and methods of use thereof Human Necessities 32 Active
US8496957B2 Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders Human Necessities 25 Active
US8575122B2 Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders Human Necessities 23 Active
US9132087B2 Auris formulations for treating otic diseases and conditions Chemistry; Metallurgy 23 Active
US8648119B2 Controlled release immunomodulator compositions and methods for the treatment of otic disorders Human Necessities 18 Active
US8349353B2 Controlled release cytotoxic agent compositions and methods for the treatment of otic disorders Human Necessities 17 Active
US8852626B2 Controlled-release CNS modulating compositions and methods for the treatment of otic disorders Human Necessities 8 Active
US10272034B2 Auris formulations for treating otic diseases and conditions Chemistry; Metallurgy 7 Active
US9333171B2 Controlled-release CNS modulating compositions and methods for the treatment of otic disorders Human Necessities 7 Active
US9427472B2 Controlled release compositions for modulating free-radical induced damage and methods of use thereof Human Necessities 7 Active
US10092580B2 Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders Human Necessities 7 Active
US9486405B2 Methods for the treatment of pediatric otic disorders Emerging Cross-Sectional Technologies 6 Active
US9233068B2 Controlled release antimicrobial compositions and methods for the treatment of OTIC disorders Human Necessities 6 Active
US8546363B2 Controlled release corticosteroid compositions and methods for the treatment of otic disorders Human Necessities 5 Active
US9066855B2 Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders Human Necessities 4 Active
US8828980B2 Controlled release corticosteroid compositions and methods for the treatment of otic disorders Human Necessities 4 Active
US9205048B2 Controlled release antimicrobial compositions and methods for the treatment of otic disorders Human Necessities 3 Active
US9603796B2 Controlled release antimicrobial compositions and methods for the treatment of otic disorders Human Necessities 3 Active
US9744126B2 Controlled release corticosteroid compositions and methods for the treatment of otic disorders Human Necessities 3 Active
US8680082B2 Controlled release corticosteroid compositions and methods for the treatment of otic disorders Human Necessities 2 Active
US8658626B2 Controlled release corticosteroid compositions and methods for the treatment of otic disorders Human Necessities 2 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.